EARNEST Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-947
| Closed | -$55K | – | 394 |
|
2023
Q3 | $55K | Hold |
947
| – | – | ﹤0.01% | 357 |
|
2023
Q2 | $60.6K | Hold |
947
| – | – | ﹤0.01% | 337 |
|
2023
Q1 | $65.6K | Hold |
947
| – | – | ﹤0.01% | 329 |
|
2022
Q4 | $68.1K | Hold |
947
| – | – | ﹤0.01% | 328 |
|
2022
Q3 | $67K | Hold |
947
| – | – | ﹤0.01% | 309 |
|
2022
Q2 | $73K | Sell |
947
-200
| -17% | -$15.4K | ﹤0.01% | 305 |
|
2022
Q1 | $84K | Hold |
1,147
| – | – | ﹤0.01% | 303 |
|
2021
Q4 | $72K | Hold |
1,147
| – | – | ﹤0.01% | 317 |
|
2021
Q3 | $68K | Hold |
1,147
| – | – | ﹤0.01% | 317 |
|
2021
Q2 | $77K | Hold |
1,147
| – | – | ﹤0.01% | 309 |
|
2021
Q1 | $72K | Hold |
1,147
| – | – | ﹤0.01% | 305 |
|
2020
Q4 | $71K | Hold |
1,147
| – | – | ﹤0.01% | 296 |
|
2020
Q3 | $69K | Hold |
1,147
| – | – | ﹤0.01% | 289 |
|
2020
Q2 | $67K | Hold |
1,147
| – | – | ﹤0.01% | 283 |
|
2020
Q1 | $64K | Hold |
1,147
| – | – | ﹤0.01% | 279 |
|
2019
Q4 | $74K | Buy |
1,147
+358
| +45% | +$23.1K | ﹤0.01% | 285 |
|
2019
Q3 | $40K | Hold |
789
| – | – | ﹤0.01% | 331 |
|
2019
Q2 | $36K | Hold |
789
| – | – | ﹤0.01% | 350 |
|
2019
Q1 | $38K | Hold |
789
| – | – | ﹤0.01% | 338 |
|
2018
Q4 | $41K | Hold |
789
| – | – | ﹤0.01% | 321 |
|
2018
Q3 | $49K | Hold |
789
| – | – | ﹤0.01% | 318 |
|
2018
Q2 | $44K | Hold |
789
| – | – | ﹤0.01% | 330 |
|
2018
Q1 | $50K | Hold |
789
| – | – | ﹤0.01% | 309 |
|
2017
Q4 | $48K | Buy |
+789
| New | +$48K | ﹤0.01% | 301 |
|
2017
Q1 | – | Sell |
-789
| Closed | -$46K | – | 331 |
|
2016
Q4 | $46K | Buy |
+789
| New | +$46K | ﹤0.01% | 288 |
|